These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 24709508)

  • 1. The effect of fluence rate on the acute response of vessel diameter and red blood cell velocity during topical 5-aminolevulinic acid photodynamic therapy.
    van Leeuwen-van Zaane F; de Bruijn HS; van der Ploeg-van den Heuvel A; Sterenborg HJ; Robinson DJ
    Photodiagnosis Photodyn Ther; 2014 Jun; 11(2):71-81. PubMed ID: 24709508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical hexylaminolevulinate and aminolevulinic acid photodynamic therapy: complete arteriole vasoconstriction occurs frequently and depends on protoporphyrin IX concentration in vessel wall.
    Middelburg TA; de Bruijn HS; Tettero L; van der Ploeg van den Heuvel A; Neumann HA; de Haas ER; Robinson DJ
    J Photochem Photobiol B; 2013 Sep; 126():26-32. PubMed ID: 23892187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Photodynamic effectiveness and vasoconstriction in hairless mouse skin after topical 5-aminolevulinic acid and single- or two-fold illumination.
    van der Veen N; Hebeda KM; de Bruijn HS; Star WM
    Photochem Photobiol; 1999 Dec; 70(6):921-9. PubMed ID: 10628304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose and timing of the first light fraction in two-fold illumination schemes for topical ALA-mediated photodynamic therapy of hairless mouse skin.
    Robinson DJ; de Bruijn HS; Star WM; Sterenborg HJ
    Photochem Photobiol; 2003 Mar; 77(3):319-23. PubMed ID: 12685661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of light fractionation with a 2-h dark interval on the efficacy of topical hexyl-aminolevulinate photodynamic therapy in normal mouse skin.
    Middelburg TA; de Bruijn HS; van der Ploeg-van den Heuvel A; Neumann HA; Robinson DJ
    Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):703-9. PubMed ID: 24284130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical 5-aminolevulinic acid-photodynamic therapy of hairless mouse skin using two-fold illumination schemes: PpIX fluorescence kinetics, photobleaching and biological effect.
    Robinson DJ; de Bruijn HS; de Wolf WJ; Sterenborg HJ; Star WM
    Photochem Photobiol; 2000 Dec; 72(6):794-802. PubMed ID: 11140268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluorescence photobleaching of ALA-induced protoporphyrin IX during photodynamic therapy of normal hairless mouse skin: the effect of light dose and irradiance and the resulting biological effect.
    Robinson DJ; de Bruijn HS; van der Veen N; Stringer MR; Brown SB; Star WM
    Photochem Photobiol; 1998 Jan; 67(1):140-9. PubMed ID: 9477772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracutaneous ALA photodynamic therapy: dose-dependent targeting of skin structures.
    Sakamoto FH; Doukas AG; Farinelli WA; Tannous Z; Su Y; Smith NA; Zurakowski D; Anderson RR
    Lasers Surg Med; 2011 Sep; 43(7):621-31. PubMed ID: 22057490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-fluence rate, long duration photodynamic therapy in glioma mouse model using organic light emitting diode (OLED).
    Guo HW; Lin LT; Chen PH; Ho MH; Huang WT; Lee YJ; Chiou SH; Hsieh YS; Dong CY; Wang HW
    Photodiagnosis Photodyn Ther; 2015 Sep; 12(3):504-10. PubMed ID: 25936596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fractionated illumination for oesophageal ALA-PDT: effect on blood flow and PpIX formation.
    van den Boogert J; van Staveren HJ; de Bruin RW; Siersema PD; van Hillegersberg R
    Lasers Med Sci; 2001; 16(1):16-25. PubMed ID: 11486333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Photodynamic therapy with 5-aminolevulinic acid induces distinct microcirculatory effects following systemic or topical application.
    Schacht V; Szeimies RM; Abels C
    Photochem Photobiol Sci; 2006 May; 5(5):452-8. PubMed ID: 16685321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fractionated illumination at low fluence rate photodynamic therapy in mice.
    Middelburg TA; Van Zaane F; De Bruijn HS; Van Der Ploeg-van den Heuvel A; Sterenborg HJ; Neumann HA; De Haas ER; Robinson DJ
    Photochem Photobiol; 2010; 86(5):1140-6. PubMed ID: 20553407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interstitial 5-ALA photodynamic therapy and glioblastoma: Preclinical model development and preliminary results.
    Tetard MC; Vermandel M; Leroy HA; Leroux B; Maurage CA; Lejeune JP; Mordon S; Reyns N
    Photodiagnosis Photodyn Ther; 2016 Mar; 13():218-224. PubMed ID: 26213327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical aminolaevulinic acid- and aminolaevulinic acid methyl ester-based photodynamic therapy with red and violet light: influence of wavelength on pain and erythema.
    Mikolajewska P; Iani V; Juzeniene A; Moan J
    Br J Dermatol; 2009 Nov; 161(5):1173-9. PubMed ID: 19785604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of 5-aminolevulinic acid-mediated photodynamic therapy on antibiotic-resistant staphylococcal biofilm: an in vitro study.
    Li X; Guo H; Tian Q; Zheng G; Hu Y; Fu Y; Tan H
    J Surg Res; 2013 Oct; 184(2):1013-21. PubMed ID: 23622723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor vascular response to photodynamic therapy and the antivascular agent 5,6-dimethylxanthenone-4-acetic acid: implications for combination therapy.
    Seshadri M; Spernyak JA; Mazurchuk R; Camacho SH; Oseroff AR; Cheney RT; Bellnier DA
    Clin Cancer Res; 2005 Jun; 11(11):4241-50. PubMed ID: 15930363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A dynamic model for ALA-PDT of skin: simulation of temporal and spatial distributions of ground-state oxygen, photosensitizer and singlet oxygen.
    Liu B; Farrell TJ; Patterson MS
    Phys Med Biol; 2010 Oct; 55(19):5913-32. PubMed ID: 20844331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microscopic localisation of protoporphyrin IX in normal mouse skin after topical application of 5-aminolevulinic acid or methyl 5-aminolevulinate.
    de Bruijn HS; Meijers C; van der Ploeg-van den Heuvel A; Sterenborg HJ; Robinson DJ
    J Photochem Photobiol B; 2008 Aug; 92(2):91-7. PubMed ID: 18571933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Irradiance and light dose influence histological localization of photodamage induced by photodynamic therapy with aminolaevulinic acid.
    Bissonnette R; Sharfaei S; Viau G; Liu Y
    Br J Dermatol; 2004 Sep; 151(3):653-5. PubMed ID: 15377353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficiency of 5-ALA mediated photodynamic therapy on hypoxic prostate cancer: a preclinical study on the Dunning R3327-AT2 rat tumor model.
    Bozzini G; Colin P; Betrouni N; Maurage CA; Leroy X; Simonin S; Martin-Schmitt C; Villers A; Mordon S
    Photodiagnosis Photodyn Ther; 2013 Sep; 10(3):296-303. PubMed ID: 23993856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.